Literature DB >> 2788278

Cardiac and neurological abnormalities in v-fps transgenic mice.

S P Yee1, D Mock, V Maltby, M Silver, J Rossant, A Bernstein, T Pawson.   

Abstract

Transgenic mice that widely express the v-fps protein-tyrosine kinase develop several independent pathological conditions, in addition to a high tumor incidence. v-fps expression and protein-tyrosine kinase activity in the heart were directly correlated with cardiac enlargement. This cardiomegaly was accompanied by severe myocardial and endocardial damage, which was concentrated in the left ventricular wall, and characterized by a progressive atrophy and necrosis of cardiac muscle fibers with concomitant fibrosis. This pathology was associated with congestive heart failure. Mice from five lines developed a marked trembling, correlated with expression of the v-fps transgene in the brain, and two lines showed a striking bilateral enlargement of the trigeminal nerves. Unlike tumor formation, these cardiac and neurological phenotypes were evident shortly after birth and showed 100% penetrance. The pleiotropic effects of the v-fps transgene suggest the involvement of protein-tyrosine kinases in mammalian neural development and cardiac function.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2788278      PMCID: PMC297733          DOI: 10.1073/pnas.86.15.5873

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  33 in total

1.  Different types of myocardial necrosis in coronary heart disease: a pathophysiologic review of their functional significance.

Authors:  G Baroldi
Journal:  Am Heart J       Date:  1975-06       Impact factor: 4.749

2.  Upstream G gamma-globin and downstream beta-globin sequences required for stage-specific expression in transgenic mice.

Authors:  M Trudel; J Magram; L Bruckner; F Costantini
Journal:  Mol Cell Biol       Date:  1987-11       Impact factor: 4.272

Review 3.  Protein-tyrosine kinases.

Authors:  T Hunter; J A Cooper
Journal:  Annu Rev Biochem       Date:  1985       Impact factor: 23.643

4.  Mutagenesis of Fujinami sarcoma virus: evidence that tyrosine phosphorylation of P130gag-fps modulates its biological activity.

Authors:  G Weinmaster; M J Zoller; M Smith; E Hinze; T Pawson
Journal:  Cell       Date:  1984-06       Impact factor: 41.582

5.  A noncatalytic domain conserved among cytoplasmic protein-tyrosine kinases modifies the kinase function and transforming activity of Fujinami sarcoma virus P130gag-fps.

Authors:  I Sadowski; J C Stone; T Pawson
Journal:  Mol Cell Biol       Date:  1986-12       Impact factor: 4.272

6.  Tissue-specific and ectopic expression of genes introduced into transgenic mice by retroviruses.

Authors:  P Soriano; R D Cone; R C Mulligan; R Jaenisch
Journal:  Science       Date:  1986-12-12       Impact factor: 47.728

7.  Nucleotide sequence of Fujinami sarcoma virus: evolutionary relationship of its transforming gene with transforming genes of other sarcoma viruses.

Authors:  M Shibuya; H Hanafusa
Journal:  Cell       Date:  1982-10       Impact factor: 41.582

8.  A strain of Fujinami sarcoma virus which is temperature-sensitive in protein phosphorylation and cellular transformation.

Authors:  T Pawson; J Guyden; T H Kung; K Radke; T Gilmore; G S Martin
Journal:  Cell       Date:  1980-12       Impact factor: 41.582

9.  Spontaneous mammary adenocarcinomas in transgenic mice that carry and express MTV/myc fusion genes.

Authors:  T A Stewart; P K Pattengale; P Leder
Journal:  Cell       Date:  1984-10       Impact factor: 41.582

10.  Purification of mouse immunoglobulin heavy-chain messenger RNAs from total myeloma tumor RNA.

Authors:  C Auffray; F Rougeon
Journal:  Eur J Biochem       Date:  1980-06
View more
  6 in total

1.  A ubiquitous factor (HF-1a) and a distinct muscle factor (HF-1b/MEF-2) form an E-box-independent pathway for cardiac muscle gene expression.

Authors:  S Navankasattusas; H Zhu; A V Garcia; S M Evans; K R Chien
Journal:  Mol Cell Biol       Date:  1992-04       Impact factor: 4.272

2.  Lymphoid and mesenchymal tumors in transgenic mice expressing the v-fps protein-tyrosine kinase.

Authors:  S P Yee; D Mock; P Greer; V Maltby; J Rossant; A Bernstein; T Pawson
Journal:  Mol Cell Biol       Date:  1989-12       Impact factor: 4.272

3.  Enhanced endotoxin sensitivity in fps/fes-null mice with minimal defects in hematopoietic homeostasis.

Authors:  Ralph A Zirngibl; Yotis Senis; Peter A Greer
Journal:  Mol Cell Biol       Date:  2002-04       Impact factor: 4.272

4.  Targeted disruption of the murine fps/fes proto-oncogene reveals that Fps/Fes kinase activity is dispensable for hematopoiesis.

Authors:  Y Senis; R Zirngibl; J McVeigh; A Haman; T Hoang; P A Greer
Journal:  Mol Cell Biol       Date:  1999-11       Impact factor: 4.272

5.  Degeneration of skeletal and cardiac muscles in c-myb transgenic mice.

Authors:  Y Furuta; S Aizawa; Y Suda; Y Ikawa; H Nakasgoshi; Y Nishina; S Ishii
Journal:  Transgenic Res       Date:  1993-07       Impact factor: 2.788

6.  Involvement of Fes/Fps tyrosine kinase in semaphorin3A signaling.

Authors:  Norihiro Mitsui; Ryoko Inatome; Shusuke Takahashi; Yoshio Goshima; Hirohei Yamamura; Shigeru Yanagi
Journal:  EMBO J       Date:  2002-07-01       Impact factor: 11.598

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.